TaiRx, Inc. (6580.TWO)
TWD 26.9
(0.94%)
TWD 26.9
(0.94%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -208.64 Million TWD | -0.71% |
| 2022 | -207.17 Million TWD | -68.46% |
| 2021 | -122.98 Million TWD | 22.06% |
| 2020 | -157.78 Million TWD | 2.64% |
| 2019 | -215.8 Million TWD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | -37.2 Million TWD | -2.2% |
| 2024 Q1 | -36.4 Million TWD | 35.48% |
| 2023 Q2 | -50.86 Million TWD | 0.0% |
| 2023 FY | - TWD | -0.71% |
| 2023 Q3 | -56.42 Million TWD | -10.93% |
| 2023 Q1 | -50.86 Million TWD | 6.77% |
| 2023 Q4 | -56.42 Million TWD | 0.0% |
| 2022 Q3 | -54.56 Million TWD | 0.0% |
| 2022 FY | - TWD | -68.46% |
| 2022 Q4 | -54.56 Million TWD | 0.0% |
| 2021 FY | - TWD | 22.06% |
| 2020 FY | - TWD | 2.64% |
| 2019 FY | - TWD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Bio Preventive Medicine Corp. | -62.34 Million TWD | -234.685% |
| Genomics BioSci & Tech. Co.,Ltd. | -103.61 Million TWD | -101.367% |
| Advagene Biopharma Co., Ltd. | -80.07 Million TWD | -160.573% |
| Taiwan Bio Therapeutics Co., Ltd | -145.97 Million TWD | -42.938% |
| NaviFUS Corp. | -55.79 Million TWD | -273.951% |
| G&E Herbal Biotechnology Co., Ltd. | 99.83 Million TWD | 308.987% |
| Sinew Pharma Inc. | -163.63 Million TWD | -27.51% |
| Lin BioScience, Inc. | -1.07 Billion TWD | 80.526% |
| TaiwanJ Pharmaceuticals Co., Ltd. | -1.73 Million TWD | -11911.86% |
| Lumosa Therapeutics Co., Ltd. | -226.67 Million TWD | 7.955% |
| Anti-Microbial Savior BioteQ Co., Ltd | -46.24 Million TWD | -351.185% |
| SYN-TECH Chem. & Pharm. Co., Ltd. | 393.6 Million TWD | 153.009% |
| AP Biosciences Inc | -325.51 Million TWD | 35.902% |
| Sunmax Biotechnology Co., Ltd. | 936.46 Million TWD | 122.28% |
| RBC Bioscience Corporation | 36.54 Million TWD | 670.898% |
| Syngen Biotech Co.,Ltd. | 433.55 Million TWD | 148.124% |
| EirGenix Inc. | -664.4 Million TWD | 68.597% |
| Enimmune corporation | -228.96 Million TWD | 8.873% |
| Lukas Biomedical Inc. | -26.3 Million TWD | -693.331% |
| BRIM Biotechnology, Inc. | -682.46 Million TWD | 69.427% |
| 3D Global Biotech Inc. | -35.84 Million TWD | -482.062% |
| TaiMed Biologics Inc. | -25.23 Million TWD | -726.878% |
| Mycenax Biotech Inc. | -339.48 Million TWD | 38.54% |
| TCI GENE Inc. | 25.98 Million TWD | 903.071% |
| SynCore Biotechnology Co.,Ltd | -17.72 Million TWD | -1077.062% |
| Oneness Biotech Co., Ltd. | -674.22 Million TWD | 69.054% |
| Eusol Biotech Co.,Ltd. | -44.95 Million TWD | -364.163% |
| Feng Chi Biotech Corp. | 34.83 Million TWD | 698.903% |
| NeoCore Technology Co., Ltd. | -72.11 Million TWD | -189.324% |
| TWi Biotechnology, Inc. | -160.85 Million TWD | -29.709% |
| Neith Corporation | -33.61 Million TWD | -520.785% |
| Sunny Pharmtech Inc. | 69.14 Million TWD | 401.76% |
| VBI | -6.97 Million TWD | -2892.628% |
| Ever Supreme Bio Technology Co., Ltd | 655.52 Million TWD | 131.829% |
| GeneReach Biotechnology Corp. | -143.69 Million TWD | -45.201% |
| Shine-On BioMedical Co.,Ltd. | -33 Million TWD | -532.146% |
| CHO Pharma, Inc. | -277.73 Million TWD | 24.875% |
| Andros Pharmaceuticals Co.,Ltd | -61.5 Million TWD | -239.262% |
| MegaPro Biomedical Co., Ltd | -110.63 Million TWD | -88.584% |
| Visgeneer Inc. | 973 Thousand TWD | 21543.577% |
| Greenyn Biotechnology Co., Ltd | 192.4 Million TWD | 208.443% |
| BioLASCO Taiwan Co., Ltd. | 73.9 Million TWD | 382.32% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | -16.59 Million TWD | -1157.055% |
| Sagittarius Life Science Corp | -44.73 Million TWD | -366.363% |
| BioGend Therapeutics Co., Ltd. | -113.1 Million TWD | -84.469% |
| GlycoNex Incorporation | -126.82 Million TWD | -64.512% |
| Medigen Biotechnology Corp. | -1.04 Billion TWD | 80.027% |
| Pharmosa Biopharm Inc. | 29.13 Million TWD | 816.258% |
| PharmaEngine, Inc. | 347.3 Million TWD | 160.076% |
| Intech Biopharm Corporation | -219.58 Million TWD | 4.982% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 21.81 Million TWD | 1056.653% |
| BiOptic Inc. | 65.03 Million TWD | 420.806% |
| TaiGen Biopharmaceuticals Holdings Limited | 172.23 Million TWD | 221.144% |
| Senhwa Biosciences, Inc. | -283.78 Million TWD | 26.477% |
| NatureWise Biotech & Medicals Corporation | 13.85 Million TWD | 1606.469% |
| OBI Pharma, Inc. | -855.08 Million TWD | 75.599% |
| Savior Lifetec Corporation | 219.6 Million TWD | 195.01% |
| Great Novel Therapeutics Biotech & Medicals | -54.91 Million TWD | -279.944% |
| Level Biotechnology Inc. | 98.7 Million TWD | 311.386% |
| Medigen Vaccine Biologics Corporation | -991.09 Million TWD | 78.948% |
| Meribank Biotech Co., Ltd | -92.56 Million TWD | -125.41% |
| Acepodia, Inc. | -764.51 Million TWD | 72.709% |
| Caliway Biopharmaceuticals Co., Ltd. | -460.09 Million TWD | 54.651% |